Flow cytometric parameters with little interexaminer variability for diagnosing low-grade myelodysplastic syndromes

Leukemia Research

Volumn 32, Issue 5, 2008, Pages 699-707

  Satoh, Chikako ^a   Dan, Kazuo ^a   Yamashita, Taishi ^a,b   Jo, Risa ^a,b   Tamura, Hideto ^a   Ogata, Kiyoyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

CD34; CD45; Flow cytometry; Myeloblasts; Myelodysplastic syndromes

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MYELOBLAST; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ANTIGENS, CD34; ANTIGENS, CD45; FLOW CYTOMETRY; HUMANS; MYELODYSPLASTIC SYNDROMES;

EID: 40049110108     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2007.08.022     Document Type: Article

References (27)

1. Ogata K. Myelodysplastic syndromes: recent progress in diagnosis and understanding of their pathophysiology. J Nippon Med Sch 73 (2006) 300-307
2. Toyama K., Ohyashiki K., Yoshida Y., Abe T., Asano S., Hirai H., et al. Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan. Leukemia 7 (1993) 499-508
3. Sole F., Espinet B., Sanz G.F., Cervera J., Calasanz M.J., Luno E., et al. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes Grupo Cooperativo Espanol de Citogenetica Hematologica. Br J Haematol 108 (2000) 346-356
4. Stetler-Stevenson M., Arthur D.C., Jabbour N., Xie X.Y., Molldrem J., Barrett A.J., et al. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 98 (2001) 979-987
5. Kussick S.J., and Wood B.L. Using 4-color flow cytometry to identify abnormal myeloid populations. Arch Pathol Lab Med 127 (2003) 1140-1147
6. Wells D.A., Benesch M., Loken M.R., Vallejo C., Myerson D., Leisenring W.M., et al. Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102 (2003) 394-403
7. Cherian S., Moore J., Bantly A., Vergilio J.A., Klein P., Luger S., et al. Peripheral blood MDS score: a new flow cytometric tool for the diagnosis of myelodysplastic syndromes. Cytometry B Clin Cytom 64 (2005) 9-17
8. Malcovati L., Della Porta M.G., Lunghi M., Pascutto C., Vanelli L., Travaglino E., et al. Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome. Leukemia 19 (2005) 776-783
9. Ogata K., Kishikawa Y., Satoh C., Tamura H., Dan K., and Hayashi A. Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes. Blood 108 (2006) 1037-1044
10. Pirruccello S.J., Young K.H., and Aoun P. Myeloblast phenotypic changes in myelodysplasia CD34 and CD117 expression abnormalities are common. Am J Clin Pathol 125 (2006) 884-894
11. Valent P., Horny H.-P., Bennett J.M., Fonatsch C., Germing U., Greenberg P., et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 31 (2007) 727-736
12. Loken M., van de Loosdrecht A., Ogata K., Orfao A., and Wells D.A. Flow cytometry in myelodysplastic syndromes: report from a working conference. Leuk Res 32 (2008) 5-17
13. Elghetany M.T. Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome. Blood 99 (2002) 391
14. Stetler-Stevenson M., Rick M., and Arthur D. Diagnostic flow cytometric immunophenotyping in myelodysplastic syndrome: the US-Canadian consensus recommendations on the immunophenotypic analysis of hematological neoplasia by flow cytometry apply. Blood 99 (2002) 392
15. Ogata K., Nakamura K., Yokose N., Tamura H., Tachibana M., Taniguchi O., et al. Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome. Blood 100 (2002) 3887-3896
16. Stelzer G.T., Marti G., Hurley A., McCoy Jr. P., Lovett E.J., and Schwartz A. U S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 30 (1997) 214-230
17. Baumgarth N., and Roederer M. A practical approach to multicolor flow cytometry for immunophenotyping. J Immunol Methods 243 (2000) 77-97
18. Roederer M. Spectral compensation for flow cytometry: visualization artifacts, limitations, and caveats. Cytometry 45 (2001) 194-205
19. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
20. Landis J.R., and Koch G.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 33 (1977) 363-374
21. Chinn S., and Schouten J.P. Reproducibility of non-specific bronchial challenge in adults: implications for design, analysis and interpretation of clinical and epidemiological studies. Thorax 60 (2005) 395-400
22. Ogata K., and Yoshida Y. Clinical implications of blast immunophenotypes in myelodysplastic syndromes. Leuk Lymphoma 46 (2005) 1269-1274
23. Gratama J.W., D'Hautcourt J.L., Mandy F., Rothe G., Barnett D., Janossy G., et al. Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives European Working Group on Clinical Cell Analysis. Cytometry 33 (1998) 166-178
24. Paxton H., and Bendele T. Effect of time, temperature, and anticoagulant on flow cytometry and hematological values. Ann NY Acad Sci 677 (1993) 440-443
25. Nguyen D., Diamond L.W., and Braylan R.C. FCM immunophenotyping and DNA analysis: practical aspects that can affect data analysis and interpretation. Flow cytometry in hematopathology (2003), Humana Press, New Jersey p. 9
26. Stewart C.C., and Stewart S.J. Cell preparation for the identification of leukocytes. In: Darzynkiewicz Z., Robinson J.P., and Crissman H.A. (Eds). Flow cytometry (1994), Academic Press, New York 39
27. Baur A.S., Meuge-Moraw C., Schmidt P.M., Parlier V., Jotterand M., and Delacretaz F. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes. Eur J Haematol 64 (2000) 71-79